Latest filing published 28 Jul 2020 for GlaxoSmithKline plc.
Insider track record
E N Walmsley: trading record in brief
This profile gathers the share dealings of E N Walmsley in GlaxoSmithKline plc. Between 12 October 2018 and 27 July 2020, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 28 July 2020, reports a share grant in GlaxoSmithKline plc. Typically, a trade is published a median of 3 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to E N Walmsley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 277,623 sharesN/AISIN GB0009252882FCA-NSM:3670052
- 1,856.065 shares@ £15.500956.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190416171422_14043624_20200326185042776_11229-0
- 1,535.597 shares@ £15.287543.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190115171501_13935643_20200326185116240_17223-0
- 1,588.542 shares@ £14.587930.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20181016165353_13831182_20200330111443187_13744-0
4 of 4 declarations